These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3496102)

  • 1. Therapeutic activities of nitrothiazoles against trichomonads.
    Hof H; Müller KM; Schrank W; Schweizer EH; Zak O
    Arzneimittelforschung; 1987 Mar; 37(3):306-9. PubMed ID: 3496102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.
    Meingassner JG; Nesvadba H; Mieth H
    Arzneimittelforschung; 1981; 31(1):6-8. PubMed ID: 6971111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure-activity correlations in the series of antimicrobially active nitrothiazoles].
    Kutter E; Machleidt H; Reuter W; Sauter R; Wildfeuer A
    Arzneimittelforschung; 1972 Jun; 22(6):1045-54. PubMed ID: 4559156
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mutagenic activity of nitrothiazole compounds].
    Hof H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):64-70. PubMed ID: 3901605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. 2.
    Islip PJ; Closier MD; Weale JE
    J Med Chem; 1973 Sep; 16(9):1027-30. PubMed ID: 4583270
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. 3.
    Islip PJ; Closier MD; Neville MC
    J Med Chem; 1973 Sep; 16(9):1030-4. PubMed ID: 4583271
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trichomonacidal activity of newly synthesized derivatives of benzoizothiazolinon (BIT) in vitro].
    Ziomko I; Kuczyńska E
    Wiad Parazytol; 1994; 40(1):59-64. PubMed ID: 8023507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effect of 2,4-dinitro-phenyl-substituted sugar hydrazones and phenylosazone against Trichomonas vaginalis and Tritrichomonas foetus.
    Macicková T; Kettner M; Linek K
    Pharmazie; 1990 Mar; 45(3):204-6. PubMed ID: 2381964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
    Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
    Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the susceptibility of Trichomonas hominis to some abiotic factors. I. Preliminary assessment of antitrichomonal activity of selected compounds in vitro].
    Chomicz L; Zebrowska J; Zawadzki P; Myjak P; Perkowski K; Rebandel H; Kazimierczuk Z
    Wiad Parazytol; 2004; 50(3):405-9. PubMed ID: 16865945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physical-chemical properties and antitrichomonal effect of 2-, 4-, and 5-nitroimidazoles].
    Sunjić V; Kajfez F; Kolbah D; Blazević N
    Pharmazie; 1972 Mar; 27(3):131-8. PubMed ID: 4558978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Trichomonacidal properties of nimorazole].
    Cavier R; Cénac J
    Therapeutique; 1972; 48(5):391-4. PubMed ID: 4538614
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitrichomonal activity and docking analysis of thiazole derivatives as TvMP50 protease inhibitors.
    Mena-Rejón G; Pérez-Navarro Y; Torres-Romero JC; Vázquez-Carrillo L; Carballo RM; Arreola R; Herrera-España Á; Arana-Argáez V; Quijano-Quiñones R; Fernández-Sánchez JM; Alvarez-Sánchez ME
    Parasitol Res; 2021 Jan; 120(1):233-241. PubMed ID: 33073325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.
    Bitencourt FG; de Brum Vieira P; Meirelles LC; Rigo GV; da Silva EF; Gnoatto SCB; Tasca T
    Parasitol Res; 2018 May; 117(5):1573-1580. PubMed ID: 29572567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
    He Y; Tao X; Guan L; Lian W
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitrichomonal properties of an antiseptic drug cidizol-KB].
    Kravchenko VG; Vasil'ev MM
    Vestn Dermatol Venerol; 1984 Dec; (12):31-2. PubMed ID: 6335801
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro sensitivity of 50 Trichomonas vaginalis strains to CP 12 574].
    Kremer M; Miltgen F; Dellenbach P
    Rev Fr Gynecol Obstet; 1972 Nov; 67(11):655-7. PubMed ID: 4540771
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancement of the antitrichomonal activity of 5-nitroimidazole derivatives by hydrogen peroxide.
    Mattana A; Juliano C; Picci V; Franconi F; Cappuccinelli P
    New Microbiol; 1993 Oct; 16(4):359-65. PubMed ID: 8264426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.